Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shveta Monga
Observed names:
Monga, Shveta,
S Monga
Institutions:
Great Western Hospital,
University of Oxford,
Great Western Hospitals NHS Foundation Trust
Observed institutions:
Cheltenham General Hospital,
Great Western Hospital,
John Radcliffe Hospital,
University of Oxford,
Great Western Hospitals NHS Foundation Trust
ORCID:
0000-0002-2928-4209
Observed ORCID:
0000-0002-2928-4209
OpenAlex ID:
A5033753375
Assessment of Cardiac Energy Metabolism, Function, and Physiology in Patients With Heart Failure Taking Empagliflozin: The Randomized, Controlled EMPA-VISION Trial
2023
·
Moritz J. Hundertmark
, Amanda Adler
, et al.
·
Circulation
·
133
PDF
Insights Into the Metabolic Aspects of Aortic Stenosis With the Use of Magnetic Resonance Imaging
2022
·
Shveta Monga
, Ladislav Valkovič
, et al.
·
JACC. Cardiovascular imaging
·
17
PDF
Role of Cardiac Energetics in Aortic Stenosis Disease Progression: Identifying the High-risk Metabolic Phenotype
2023
·
Shveta Monga
, Ladislav Valkovič
, et al.
·
Circulation Cardiovascular Imaging
·
15
PDF
Tools and Techniques - Clinical. Update on coronary guidewires 2016: chronic total occlusions
2016
·
Peregrine Green
, Shveta Monga
, et al.
·
EuroIntervention
·
3
Fenofibrate modulates cardiac energy metabolism in moderate-severe aortic stenosis: a mechanistic double-blinded randomised controlled MR trial
2024
·
S Monga
, L Valkovic
, et al.
·
European Heart Journal
·
1
29 Role of cardiac energetics in aortic stenosis disease progression: identifying the high-risk metabolic phenotype
2023
·
Shveta Monga
, Ladislav Valkovič
, et al.
·
Heart
·
1
PDF
Characterisation of metabolic phenotype in aortic stenosis: insights from a multi-parametric cardiac magnetic resonance study
2022
·
S Monga
, L Valkovic
, et al.
·
European Heart Journal
·
1
PDF
93 Conduction system pacing in a district general hospital: a five-year experience
2024
·
Pok-Tin Tang
, Nadiya Johal
, et al.
·
Heart
30 A randomised double-blind placebo-controlled study of fenofibrate as a metabolic modulator to augment cardiac physiology in moderate-severe aortic stenosis
2023
·
Shveta Monga
, Ladislav Valkovič
, et al.
·
Heart
PDF
Abstract 13777: Metabolic Phenotyping in Aortic Stenosis: Insights From a Multi-Parametric Cardiac Magnetic Resonance Study
2022
·
Shveta Monga
, Ladislav Valkovic
, et al.
·
Circulation
Abstract 13652: A Randomised Double-Blind Placebo-Controlled Study of Fenofibrate as a Metabolic Modulator to Augment Cardiac Physiology in Moderate-Severe Aortic Stenosis
2022
·
Shveta Monga
, Ladislav Valkovic
, et al.
·
Circulation
OP2 A randomised double-blind placebo-controlled study of fenofibrate as a metabolic modulator to augment cardiac physiology in moderate-severe aortic stenosis
2022
·
Shveta Monga
, Ladislav Valkovič
, et al.
·
Heart
PDF
OP3 Metabolic phenotyping in aortic stenosis: insights from a multi-parametric cardiac magnetic resonance study
2022
·
Shveta Monga
, Ladislav Valkovič
, et al.
·
Heart
PDF
18 Upgrade to defibrillator in patients receiving cardiac resynchronisation therapy pacemakers
2017
·
Shveta Monga
, Dominic Haigh
, et al.
·
Heart
19 Modified fraility index as predictor of outcome for patients implanted with cardiac resynchronisation therapy
2017
·
Shveta Monga
, Dominic Haigh
, et al.
·
Heart
PDF
An unusual complication during implantation of an internal cardioverter-defibrillator: A Case Report
2017
·
Shveta Monga
, Atique Imam
, et al.
·
Current research. Cardiology
PDF
56-64: Mortality in patients implanted with cardiac resynchronisation therapy with or without a defibrillator
2016
·
Shveta Monga
, Giles Atton
, et al.
·
EP Europace
PDF
Mortality in patients implanted with cardiac resynchronisation therapy with or without a defibrillator
2016
·
Shveta Monga
, Giles Atton
, et al.
·
European Journal of Heart Failure
Show more works
View as search
Works count:
19
Citation count:
171
H-index:
3
I10-index:
3
Year
Topic
Type
